Skip to main content
. 2016 Sep 20;12(5):3121–3129. doi: 10.3892/etm.2016.3720

Table I.

Baseline demographics of patients, comparing etiology.

Variable Viral (n=108) Non-viral (n=130) P-value
Gender (%) <0.001
  Male 72 (66.7) 51 (39.2)
  Female 36 (33.3) 79 (60.8)
Age, mean years±SD 35.1±15.8 38.3±19.3 0.186
Type (%) <0.001
  ALF 46 (42.6) 27 (20.8)
  SALF 62 (57.4) 103 (79.2)
Coma grade (%) 0.004
  0 45 (41.7) 90 (69.2)
  1 0 (0.0) 1 (0.8)
  2 21 (19.4) 16 (12.3)
  3 27 (25.0) 18 (13.8)
  4 12 (11.1) 8 (6.2)
Steroid use <0.001
  Total number of patients (%) 37 (34.3) 18 (13.8)
  Daily Dex dose, mg/d (range) 10 (5–20) 10 (5–30)
  Days of steroid use, mg/d (range) 5 (1–90) 5 (1–60)
Mean MELD 31.3±6.2 30.2±6.5 0.162
Laboratory values
  ALT, IU/l 1428±1637 591±740 <0.001
  AST, IU/l 1229±1745 643±938 0.001
  T-Bil, mg/dl 21.4±10.3 24.2±11.2 0.050
  Cr, mg/dl 1.22±0.59 1.20±0.59 0.822
INR 3.35±1.70 3.08±2.02 0.268

Data are expressed as number of patients in each group, unless indicated otherwise. SD, standard deviation; ALF, acute liver failure; SALF, subacute liver failure; Dex, dexamethasone; MELD, Model for End-stage Liver Disease; ALT, alanine aminotransferase; AST, aspartate aminotransferase; T-Bil, serum total bilirubin; Cr, creatinine; INR, international normalized ratio.